To quantify the difference in long-term survival and cardiovascular morbidity between women and men undergoing elective abdominal aortic aneurysm (AAA) repair at NHS hospitals in England.
Introduction 1
The incidence of abdominal aortic aneurysms (AAA) is known to be approximately four to six times 2 higher in men than in women. There are also sex differences in outcomes after endovascular and open 3 AAA repair and in risk of rupture.(1) It has long been suggested that when undergoing aneurysm 4 treatment, women are exposed to higher perioperative mortality risks with both elective open surgery 5 and endovascular aneurysm repair (EVAR). Several explanations have been proposed for these poorer 6 outcomes. First, in many series describing elective AAA repair, women tend to be older and have 7 more frequent atherosclerotic risk factors than men.(2) In addition, anatomic differences between the 8 sexes have resulted in higher rates of procedural complications and reinterventions in women after an 9 EVAR.(3, 4) In the UK Small Aneurysm Trial, the risk of rupture in women was 4-fold that of 10 men.(5) 11
12 Studies on open elective AAA repair have however shown conflicting results. One review of multiple 13 population-based reports concluded that there was discrepancy in results, with some studies showing 14 similar mortality and others finding higher mortality for women undergoing elective AAA repair.(6) 15
The natural history of women with AAA is largely unknown due to the modest representation of 16 female patients in most studies analysing AAA. In the American College of Surgeons National 17 Surgical Quality Improvement Program (NSQIP) data set of 3662 EVARs, only 17·7% were 18 women.(7) Women have also been under-represented in three large randomised clinical trials 19
comparing EVAR and open repair for elective AAA. In the OVER trial,(8) women comprised only 20 0·6% of the study population; in the United Kingdom (UK) EVAR trial and Dutch Randomized 21 Endovascular Aneurysm Repair (DREAM) trial, women comprised 9% of the study population.(9, 10) 22 23 Ultrasound screening for AAA is being implemented in men aged 65 years in several countries, 24 however a prevailing opinion is that general screening for AAA in women is not indicated as the only 25 randomised study including women demonstrated no reduction in mortality(11). High peri-operative 26 mortality might negatively affect cost-effectiveness for screening. In addition to implications for 27   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 screening, there has been an ongoing debate about the optimum size threshold to offer surgery for 1 asymptomatic AAA in women. A recent review has concluded that that any excess rupture risk in 2 women (vs. men) with AAAs of 5·0-5·5 cm diameter is offset by an increase in operative mortality 3 and therefore there is no convincing evidence or argument that women with 5-cm diameter aneurysms 4 should be offered early elective repair.(12) 5 6 While several authors have included the influence of gender on outcomes following AAA repair, the 7 current literature suffers from inherent deficiencies. Few studies to date have performed an in-depth 8 analysis examining the characteristics of AAA patients based on gender in an effort to identify an 9 independent association. Relevant evidence for women from randomised clinical trials is unlikely to 10 become available in the foreseeable future. The objective of this study was to quantify the difference 11 in long-term survival and cardiovascular morbidity between women and men undergoing elective 12
AAA repair (open and EVAR) at National Health Service (NHS) hospitals in England using a large 13 contemporary dataset. 14 15   16   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 6 Methods 1 2
Data Set 3
In this observational study, we linked patient level data from two large United Kingdom (UK) 4 datasets to examine these questions: the Office of National Statistics (ONS) and the Hospital Episode 5
Statistics for England (HES). ONS is responsible for collecting and publishing statistics related to the 6 economy, population and society at national, regional and local levels. It also conducts the census in 7
England and Wales every ten years. HES are a data warehouse containing details of all admissions, 8 outpatient appointments and accident and emergency attendances at NHS hospitals in England. HES' 9 information is stored as a large collection of separate records, one for each period of care, in a secure 10 data warehouse. Each record should include information on patients' demographic characteristics as 11 well as their main and supplementary diagnoses and operations. Through linkage with mortality data 12 from the ONS, HES also contains information about date of death irrespective of whether the patient 13 died in hospital or after discharge. We bioinformatically searched through 181·98 million HES 14 records from 1 April 2002 to 31 March 2013 and 4·82 million ONS records for the same duration. 15
16

Patient Selection 17
The data extraction process detected all episodes for all spells in which International Classification of 18 Diseases version 10 (ICD-10) diagnostic codes I71·4 (abdominal aortic aneurysm, without mention of 19
rupture) or Office of Population Censuses and Surveys Classification of Surgical Operations and 20
Procedures, fourth revision (OPCS-4), procedural codes were used (13, 14) (see Supplementary  21 material online, Table S1 ). A hospital episode is defined as the period of care led by one hospital 22 team during the corresponding data year and contains two unique identifiers, one specific for the 23 episode and the other patient-specific. 24
All patients selected had been coded as having undergone elective repair of infrarenal AAA. Patients 25 presenting with rupture or emergency admission with AAA were not included. The included patients 26
were further linked to all-cause mortality data to identify death from any cause (also coded by ICD-27 10) and any place (hospital or otherwise), obtained from the ONS dataset using an anonymised unique 28 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 7 patient identifier. Women and men having open AAA repair were sub-grouped for the entire duration 1 of 11 years of the study and comparative analyses were performed. However, patients with EVAR 2 (men and women) were only analysed from 2006 to 2013 to reflect the introduction of new OPCS-4 3 codes for endovascular aortic procedures in 2006. All identified patient episodes having EVAR prior 4 to 1 January 2006 were excluded from the analysis. Data were extracted for patient age and sex, 5 length of hospital stay (through admission and discharge dates), and date, timing and cause of death 6 (if the patient had died during the study period). 7 8
The Royal College of Surgeons (RCS) Charlson Score 9
The Charlson Score has been developed by the RCS Comorbidity Consensus group and validated in 10 terms of its association with known risk factors for co-morbidity as well as its ability to predict 11 postoperative mortality after several common surgical procedures. (15) We have used the ICD-10 12 codes (see Supplementary material online, Table S2 ) and searched through the episodes one year prior 13 to the index episode, to obtain the individual comorbities in all patients. Data on comorbidities were 14 available for all patients irrespective of prior hospitalisation. 15
16
Outcomes 17
The primary outcomes were 30-day operative mortality for elective open or endovascular repair of 18 AAA, and mid-term and long-term survival within 1 and 5 years of the index operation. All-cause 19 mortality and aortic-related mortality(16) were compared between men and women (see 20
Supplementary material online, Table S3 ). Aortic-related mortality was assessed using causes of death 21 as defined by ICD-10 codes. All ICD-10 aortic codes (aorta at any part) were included, and codes 22 referring to a cause of death closely related to complications subsequent to abdominal aortic 23 procedures were also included. 24 The secondary outcomes were post-operative morbidity and a number of complications were recorded 1 and grouped (see Supplementary material online, Table S4 ).(13) Only morbidities in the same hospital 2 stay related to the index procedure were considered in both the groups. Patients with evidence of 3 congestive cardiac failure (CCF) based on the Charlson score were identified using the following 4 ICD-10 codes: I11 (hypertensive heart disease), I13 (hypertensive heart and renal disease), I255 5 datasets on survival time, based on aortic-related mortality and other-cause mortality, were also 1 generated for both open repair and EVAR groups. We analysed the data on survival time using three 2 different approaches. First, we constructed Kaplan-Meier survival curves of all-cause mortality data, 3 and compared the mean survival proportions between women and men using the log-rank test. 4
Secondly, we fitted a Cox semiparametric proportional hazard model of all-cause mortality data 5 incorporating age and sex as predictor variables. Finally, we fitted a semiparametric proportional 6 hazards model for the sub-distribution hazard(17) of aortic-related and other-cause mortality including 7 sex and age as predictor variables. The cumulative incidence of a competing risk between women and 8 men was compared according to Gray(18). We assessed the proportionality assumption of the hazards 9 function (for both proportional hazard models) by testing artificial time-depended covariates and 10 visualising Schoenfeld residuals. 11 12 All statistical tests were two-sided with type 1 error rate of 0.05 to determine the statistical significance. 13
Statistical analyses were performed using IBM® SPSS® statistics version 22, and R software version Comparison of the patients' pre-operative characteristics based on Charlson score showed significant 7 differences between men and women for several pre-operative variables in both open repair and 8 EVAR groups (Tables 1a and 1b) . 9
10
In the open repair group (Table 1a) , the women were older (mean age 74 vs. 72 years in men), had 11 higher incidence of congestive cardiac failure (odds ratio (OR) 1·18; 95% confidence interval (CI) 12 1·01-1·36; P=0·032), chronic pulmonary disease (OR 1·38; 95% CI 1·27-1·51; P<0·001), 13 rheumatological disease (OR 2·46; 95% CI 1·97-3·06; P<0·001), and hemiplegia or paraplegia (OR 14 1·75; 95% CI 1·22-2·50; P=0·002). However, the incidence of cardiovascular risk factors was lower 15 in women, including previous myocardial infarction (OR 0·70; 95% CI 0·60-0·80; P<0·001), diabetes 16 mellitus (OR 0·77; 95% CI 0·68-0·87; P<0·001) and peripheral vascular disease (OR 0·77; 95% CI 17 0·70-0·84; P<0·001). In addition, women were less likely to have previous malignancy. The total 18 numbers of comorbidities in the RCS Charlson score (absolute score) were not statistically significant 19 (P=0·105) between women and men (Table 1a) . 20
21
In the EVAR group (Table 1b) , similar to the open repair group, women were older (mean age 77 vs. 22 75 years in men). In addition, women had higher incidence of dementia (OR 1·75; 95% CI 1·07-2·86; 23 P=0·023), chronic pulmonary disease (OR 1·21; 95% CI 1·08-1·36; P=0·001) and rheumatological 24 disease (OR 2·29; 95% CI 1·74-3·02; P<0·001). Women had lower incidence of cardiovascular risk 25 factors, including previous myocardial infarction (OR 0·62; 95% CI 0·47-0·83; P=0·001), and 26 diabetes mellitus (OR 0·62; 95% CI 0·53-0·73; P<0·001). Women were more likely to have RCS 27   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 65 1 (Table 1b) . 2 3 Both crude cumulative mortality and aortic-related mortality were higher in women compared with 4 men at 30 days, 1-year and 5-years after open repair as well as EVAR (Table 2a and 
2b). As shown in 5
Tables 3a and 3b, women had a significantly higher risk of developing respiratory complications, 6 other cardiac complications (excluding myocardial infarction, which was not significantly different 7 between the women and men) and disseminated intravascular coagulation in the AAA group within 8 30-days of surgery. In the EVAR group at 30-days, women had a significantly higher risk of acute 9 renal failure, respiratory complications, systemic infection, mechanical graft failure and other local 10 complications than men. 11
12
Based on multi-variable logistic regression model (Table 4a and term survival than men (P=0·006); a female patient is 8% more likely to die compared with a male 26 patient of identical age (95% CI of hazard ratio: 1.023, 1.141). Long-term all-cause survival 27 proportions were not statistically significantly different (P=0·356) between women and men in the 28 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 EVAR group. Apart from the gender difference, long-term all-cause survival models indicate that 1 increased age significantly increased the hazard rate for both groups (P<0·001). For each additional 2
year of age, the estimated hazard of the patient increased by 5% (EVAR group, 95% CI: 1·043, 3 1·054) to 6% (open repair group, 95% CI: 1·057, 1·064). were statistically significant for both open repair (P<0·001 for both age and sex) and EVAR (P=0·002 8 for age and P<0·001 for sex). In the EVAR group, mean cumulative incidence probabilities for the 9 aortic-related mortality were significantly (P<0·001) higher in women than men, but the difference 10 was not statistically significant (P=0·235) for the other-cause mortality. In the open repair group, the 11 women showed significantly (P<0·001) higher cumulative incidence probabilities for both aortic and 12 other-cause mortalities. In the open repair group, we observed that the other-cause mortality showed 13 an increasing trend in men just before the 10 th year. By refitting the model with categorised age 14 groups, we observed that the mean cumulative incidence probabilities were not significantly different 15 between men and women in the oldest age category (P=0·380). While the age could be an influencing 16 factor to increase the mortality rate at later time points, hence partly explaining such a trend, limited 17 information available from the data on other predictors at those time points. We, however, did not 18 observe any such trend in the EVAR group during the study period .  19   20   21   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Discussion 1 This analysis of a large, contemporary dataset demonstrated that women having open repair or EVAR 2 for AAA at NHS hospitals in England have significantly higher short-and long-term mortality 3 compared with men. Female sex is a risk factor for 30-day mortality after both types of aneurysm 4 repair. Women were older than men and had higher incidence of chronic pulmonary disease and 5 rheumatological disease, but the presence of cardiovascular risk factors was significantly lower in 6 women. Women also experienced significantly higher incidences of several post-operative 7 complications. Our study is based on the strength of HES database: it covers a complete population 8 by using routine hospital data, and thus reflects unselected national outcomes. The 30-day mortality is 9 high as reported by other studies in the literature. However, randomised controlled trials evaluating 10 the mortality after aortic aneurysm repair have strict patient selection schemes. Furthermore, these 11 trials are conducted in high-volume referral institutions, thus creating further deviation from actual 12 practice. These real-world cases are included in our analyses, making them more generalised. Our 13 results are also derived from the analyses of a significantly larger sample of patients over a long 14 duration. These factors reflect higher mortality in our study, and this difference iterates the need for 15 patient-specific risk assessment and treatment. In our study, women having AAA repair were older (average age 2 years more) and this is similar to 19 other retrospective studies (3, 20). The demographic features and comorbidities observed in our 20 patient group were also similar to other reports. Egorova et al(20) reported gender-specific outcomes 21 from the Medicare national database in United States, and women had lower incidence of previous 22 coronary artery disease and diabetes as compared to men. As noted in our study, women also had a 23 higher incidence of pulmonary disease. However, contrary to our observation, women had a higher 24 incidence of peripheral arterial disease in their study. The Canadian Society for Vascular Surgery 25
Aneurysm Study Group identified that women represented 19·7% of elective AAA repairs and were 26 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 more likely to be older, have never smoked, have a positive family history for AAA, and have a 1 coexisting history of aortoiliac occlusive disease with lower average size for AAA with lower 2 incidence of previous myocardial infarction (21). Our study showed lower incidence of cardiovascular 3 risk factors in women compared with men, although data on smoking were not available. women had significantly higher mortality (3·4% vs. 2·1%; P=0·01) and morbidity (17·8% vs. 10·6%; 23 P<0·001) (7). Regression analysis confirmed gender adversely predicted survival. The exact reasons 24 for these poorer outcomes were, however, unclear. Twelve-year follow-up of patients in the UK Small 25 Aneurysm Trial confirms that standardised mortality of these patients compared with general 26 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 population was 1·53 (95% CI 1·41-1·66) in men versus 2·44 (95%CI 2·06-2·90) in women (5). In the 1 European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) 2 database, women undergoing EVAR had higher complication rates and higher incidence of the 3 composite end point (mortality, systemic complication, or conversion), however, there was no 4 difference in 30-day mortality (1·9% for both men and women) (23). The Kaplan-Meier curves 5 demonstrated worse outcomes in women for both long-term survival and long-term event-free 6
survival. It has to be noted that the last patient enrolled in the EUROSTAR registry in this report was 7
in November 2006 and our report on EVAR patients is between January 2006 and March 2013. In 8 addition, only 623 women were represented in this registry as compared to 2036 patients in our report 9 from the HES database. The same limitations apply to three randomised clinical trials of endovascular 10 AAA repair demonstrating no difference between men and women (24-26). All these trials had a very 11 small sample size for women and they were not powered to detect sex differences. 12
13
We reviewed the literature to identify potential reasons for worse outcome following AAA repair in 14 women. It is generally accepted that women have smaller access vessels, especially relevant in EVAR 15 leading to increased risk of procedure-related complications (27). It is also generally accepted that 16 coronary heart disease is underdiagnosed and undertreated in women (28). Furthermore, it is not 17 known if increased use of statins will improve long-term survival in women with AAA. Prescription 18 of statins appears lower for women than in men; therefore, treatment practices may favour men over 19
women (29). Strong emerging evidence from clinical trials (Dutch Echographic Cardiac Risk 20
Evaluation Applying Stress Echo II and IV [DECREASE II and IV]) suggests that lack of medical 21 optimisation before procedures has a major adverse effect on perioperative cardiovascular mortality 22 and morbidity (30, 31) and similar condition could have more detrimental effect on the women 23 patients .  24   25   26   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
Limitations of the study 1
Despite being one of the largest reported series on open as well as endovascular AAA repair in 2 women and men, the present study is limited to the confines of well-controlled prospective studies. 3
The data on smoking, medications, aneurysm size, neck length or diameter, intraoperative details 4 including technical success rate, type of anaesthesia, blood loss and procedure duration, and specific 5 procedure-related complications including endoleak, limb ischaemia and need for secondary 6 procedures were not available. However, despite these limitations, this is one of the largest studies to 7 review gender-specific outcomes following AAA repair without any bias from reporting institutions 8 or industry. It represents real-world experience across the country, and as such, the findings could 9 caution surgeons to adequately counsel women undergoing AAA repair that they are likely to be at 10 increased risk of post-operative death and morbidity. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  1 We observed sustained gender-associated disparities in post-operative short and long-term mortality 2 and cardiovascular morbidity after elective AAA repair at NHS hospitals in England. Women patients 3 have higher crude 30-day, 1-year, 5-year and aortic-related mortality compared with men for both 4 types of AAA repair. More emphasis on preoperative diagnosis of undetected cardiovascular disease 5 and medical optimisation may help improving outcomes in the women patient population following 6 both open repair and EVAR. In addition, further endovascular device development, in addition to 7 focusing on features such as conformability, placement accuracy and greater attention to lower profile 8 devices to better suit the female anatomy may help in minimising the sex-based disparity in outcomes 9 after EVAR. Lastly, these data support the argument against reducing AAA size threshold for 10 intervention in women despite the increased rupture risk in women with small AAA (12, 32) . 11
Conversely, it may be that further work is required to determine if the AAA size threshold for 12 intervention in women should actually be higher than in men. 13
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Figure 4 1
Cumulative incidence curves of women and men, conditional on 30-day survival, for aortic-2 related mortality and other-cause of mortality in the EVAR group 3 4 Note: The y-axis scales are different for two different causes. The P-values refer to the comparison of 5 cumulative incidence probabilities between women and men. 6   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65 
